FEIBA - search results

feiba nf kit

takeda canada inc - anti-inhibitor coagulant complex - kit - 650unit - anti-inhibitor coagulant complex 650unit - hemostatics

Malta - English - Medicines Authority

medicinal product name : feiba 100 u/ml powder and solvent for solution for infusion (2500 u/25 ml)

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics

United States - English - NLM (National Library of Medicine)

feiba- anti-inhibitor coagulant complex kit

takeda pharmaceuticals america, inc. - anti-inhibitor coagulant complex (unii: cs849dun3m) (anti-inhibitor coagulant complex - unii:cs849dun3m) - anti-inhibitor coagulant complex 500 [usp'u] in 20 ml - feiba is an anti-inhibitor coagulant complex indicated for use in hemophilia a and b patients with inhibitors for: - control and prevention of bleeding episodes - perioperative management - routine prophylaxis to prevent or reduce the frequency of bleeding episodes. feiba is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor viii or coagulation factor ix. - known anaphylactic or severe hypersensitivity reactions to feiba or any of its components, including factors of the kinin generating system. - disseminated intravascular coagulation (dic). - acute thrombosis or embolism (including myocardial infarction). risk summary there are no data with feiba use in pregnant women to inform a drug-associated risk. there are no adequate and well-controlled studies in pregnant women. animal reproduction studies have not been conducted with feiba. it is also not known whether feiba can cause fetal harm when administered to a